SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-080307
Filing Date
2017-03-13
Accepted
2017-03-13 16:08:55
Documents
3
Period of Report
2017-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d361147d8k.htm 8-K 17094
2 EX-99.1 d361147dex991.htm EX-99.1 7084
3 GRAPHIC g361147g0314001513779.jpg GRAPHIC 2826
  Complete submission text file 0001193125-17-080307.txt   29675
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33882 | Film No.: 17685334
SIC: 8731 Services-Commercial Physical & Biological Research